# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-026534
Filing Date
2021-05-11
Accepted
2021-05-11 16:05:49
Documents
53
Period of Report
2021-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | abio-10q_20210331.htm | 10-Q | 1256920
2 | EX-10.2 | abio-ex102_75.htm | EX-10.2 | 145005
3 | EX-31.1 | abio-ex311_7.htm | EX-31.1 | 8576
4 | EX-31.2 | abio-ex312_6.htm | EX-31.2 | 8579
5 | EX-32.1 | abio-ex321_8.htm | EX-32.1 | 11227
6 | GRAPHIC | gneflb3r2gmg000002.jpg | GRAPHIC | 202155
7 | GRAPHIC | gubvrvugbnha000001.jpg | GRAPHIC | 1063
8 | GRAPHIC | gneflb3r2gmg000001.jpg | GRAPHIC | 24115
| Complete submission text file | 0001564590-21-026534.txt |  | 3844765

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL INSTANCE DOCUMENT | abio-20210331.xml | EX-101.INS | 460726
10 | XBRL TAXONOMY EXTENSION SCHEMA | abio-20210331.xsd | EX-101.SCH | 28998
11 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | abio-20210331_cal.xml | EX-101.CAL | 28546
12 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | abio-20210331_def.xml | EX-101.DEF | 66445
13 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | abio-20210331_lab.xml | EX-101.LAB | 248518
14 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | abio-20210331_pre.xml | EX-101.PRE | 174568

Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22873 | Film No.: 21911260
SIC: 2835 In Vitro & In Vivo Diagnostic Substances